Johannon Olson, RN/MBA -We Give Clinical Teams Superpowers

This 👂 podcast episode and insight’s from a16z Bio + Health's Julie Yoo spoke so clearly to the fundamental challenge facing both 🩺 clinicians and 🏥 healthcare systems.  There is a huge disconnect between supply, in the availability of clinicians, and demand, in the increasing volume and complexity of healthcare needs. -     36% of physicians plan to reduce their hours next year according to the AMA -     48% of physicians reported feeling burned out in a 2024 Medscape survey At the same time, the demographic baby boomer bubble and steady increase in the prevalence of major chronic disease, which consumes up to 90% of healthcare expenditures according to some estimates, is driving demand. With this context, Yoo points to a major opportunity for AI adoption in healthcare in 2025. Yeah, a VC hyping a wave of new AI companies that will replace the decades of training and experience of clinicians, the skeptic would say.  But Yoo is thoughtful in pointing to the role AI can play, and is already playing, through solutions such as ambient, autonomous scribe solutions (of which local star Abridge is leading the pack) in not replacing, but freeing up productivity for clinicians. There is so much unstructured context in both the complexity of disease and treatment options and the social/emotional considerations that we shouldn't be looking for AI to *replace* clinicians. But companies are getting better at finding the structured, repetitive and time-consuming places where AI tools can *help* clinicians. Nearly two-thirds of doctors cited bureaucratic tasks as the leading contributor to burnout. Rigorously trained-AI driven solutions can be a force multiplier for clinicians, and I’ve seen several interviews where nurses and doctors go as far as to say some of these solutions are ”restoring their joy in practicing medicine”. Our health is precious; and we rightly want any technology engaging with it to be developed thoughtfully and thoroughly tested. This requires top AI talent and diverse and realistic training data. Pittsburgh’s strengths in both areas is why we are an emerging hub for data-driven healthcare. #AIinhealthcare #clinicianburnout #healthinnovation #digitalhealth

15

California Bill Would Require State Review of Private Equity Deals in Healthcare — Consumer advocates and labor unions are enthusiastic about the plans, but hospitals are not A bill pending in California's legislature to ratchet up oversight of private equity investments in healthcare is receiving enthusiastic backing from consumer advocates, labor unions, and the California Medical Association, but drawing heavy fire from hospitals concerned about losing a potential funding source. Hopefully, more states will initiate the same approach to keeping close tabs on private equity buying healthcare-related entities. Private equity firms raise money from institutional investors such as pension funds and typically acquire companies they believe can be run more profitably. Then they look to boost earnings and sell the assets for multiples of what they paid for them Critics say the profit-first approach isn't good for healthcare. Look to Stewart Health Care where the CEO and C suite lined their pockets while driving the health system into the ground. "Almost all of the most distressed U.S. healthcare companies are owned by private equity firms." Time to rein in private equity vultures out there in healthcare trying to make a quick profit, raising the costs of healthcare in their quest to generate profits. #privateequity, #runningthehospitalintotheground, #vulturecapitalist, #forprofithealthcare https://lnkd.in/ea3pFz43

5

Create Health Ventures Launches Inaugural $21M Fund for Early-Stage Digital Health Startups  Create Health Ventures, a venture capital firm focused on early-stage digital health companies, has closed its debut fund, raising $21 million, surpassing its initial target. Launched in 2024, Create Health Ventures is based in Austin, TX, and Chicago, IL. The firm focuses on technologies that enhance healthcare access, improve patient experiences, and deliver value across payers, providers, and pharmaceutical companies. *Its primary focus includes:   1. Payer-Facing Technologies: Solutions that improve member experiences, enable seamless data and workflow integration, and scale technology across geographies.   2. Clinical Trial Enablement: Tools to help pharmaceutical companies recruit and retain participants for late-stage clinical trials as demand increases. *Founders and Approach:   Create Health Ventures was co-founded by Emma Cartmell and Amit Aysola, healthcare veterans with over 45 years of combined experience. They bring operational expertise, regulatory insight, and an extensive network to portfolio companies. The firm exclusively invests in startups led by healthcare industry founders, leveraging its unique value-added platform for scaling businesses.  *The platform includes: - Business development support   - Access to executive coaches   - Connections to healthcare leaders   - Cross-selling opportunities among portfolio companies  *Key Quotes by GPs:  - Emma Cartmell: “Founders from the healthcare industry understand the challenges and opportunities to improve patient outcomes. Supporting them is the most impactful way we can positively transform healthcare.”   - Amit Aysola: “Payers and pharmaceutical companies are driving demand for connected, scalable solutions, and we are investing in companies to meet these needs.”  *Investments and Impact:  The firm has made five investments so far and partners with foundations, impact investors, and strategic healthcare veterans to mentor portfolio companies.  *Portfolio CEO Feedback:   - Dr. Chip Grant (Watershed Health): “Create Health Ventures has been invaluable in scaling operations and fundraising.”   - Shara Cohen (Carallel): “They are the most collaborative and active investor team I’ve worked with.”   - Neil Batlivala (Pair Team): “They’ve helped us manage growth and reach underserved communities.” If you are experiencing difficulties in raising fresh capital and would require warm introductions to new LPs, contact G+QUANT     ▶ Please use G+QUANT's link for inquiries and fund decks, or send your inquiry directly to [email protected] #VentureCapital #DigitalHealth #HealthcareInnovation #Startups #ClinicalTrials #PatientCare #HealthTech #HealthEquity #CreateHealthVentures

7

A whirlwind of activity last week at the America's Physician Groups conference. Lots of solid insights shared by health system leaders. Some notable thoughts: +++ Artificial intelligence is intelligent in different ways: By now, we all know ai has a diverse set of use cases, incorporated in different applications and tools. But there are fundamental differences in how the intelligence itself is brought to life. Examples include: - Predictive AI, used to forecast future outcomes by leveraging historical data. Shout out to UCLA’s CKD/ESRD early intervention protocol (Joycee Berin) and Diagnostic Robotics’ intelligence care post-dicharge journeys (Kira Radinsky) - Protocolized AI, used to automating a user’s administrative load by using a set of detailed, pre-defined rule sets. Thanks to ARC for sharing their experience using Elaborate 's automated outpatient lab summaries (Manish Naik) - Generative AI, used to create new content. Great overview of ambient documentation at MGB as well as Cedars’ Sinai talking through its medical ontology model powering acute triage (Caroline Goldzweig) Across system leaders and experts, there was clear agreement that the first step to implementing intelligence intelligently is defining the ‘jobs to be done’. That way, internal and external stakeholders are clear on what they're solving for when they architect the solution.  +++ Scaling AI takes time and rigorous observation: Market leaders describe a phased pilot approach that allows clinicians to build confidence and system leaders to measure ROI before deploying systemwide. Loved hearing Rebecca Mishuris outline MGB’s novel approach of piloting two solutions against one another, to pressure test implementation, workflow, and value creation. +++ Proving ROI continues to be challenging: Lots of vendors using lots of different metrics to prove value, but the majority of leaders agreed that estimating the ROI of these new tools today is part science, part art. Demonstrating the ROI of the “soft” metrics around provider burnout and retention seemed to be a big opportunity, especially for investment in more efficient primary care and PCP wellbeing. After all, PCPs drive referrals to specialty-level care (and higher reimbursements) for health systems. Appreciated Anurang Revri's overview of how working team setup can also impact ROI estimates. +++ Value-based care = tools + humanity: VBC will require not only implementing tools to support clinical documentation, risk capture, upcoding, etc, but also humanizing interactions to engage patients. Countless examples, but one that made me smile was a depression focused chat bot responding in the following interaction: - Context: post-discharge check in Bot: Hi Freida, how are you feeling today after your surgery?  Patient: I’m having a tough time, am in a lot of pain.  Bot: Well, it can’t be that bad, I’m sure it will get better with a positive mindset!    🤣 🤣 🤣 Can't wait for next go-around!

23

2 Comments

Join host Sam Tejada in this compelling episode of ‘A Healthy Point of View’ as he sits down with Dr. Joseph Purita, a pioneer in functional and regenerative medicine, to discuss groundbreaking methods for health and longevity. Dr. Purita shares his journey from traditional orthopedics to becoming a leading expert in regenerative therapies and the science of cellular health. This conversation covers a fascinating array of topics, from Platelet-Rich Plasma (PRP) therapy and the role of mitochondria in preventing neurodegenerative diseases, to cutting-edge treatments like intermittent hypoxia therapy and extracorporeal blood oxygenation. Throughout, Dr. Purita emphasizes the importance of viewing the body as both hardware and software—highlighting how our cellular pathways and mitochondria play a pivotal role in keeping us youthful and energized. If you’re curious about the future of health, healing, and functional medicine, this episode is a must-watch. Tune in to hear insights from two health visionaries dedicated to reshaping wellness care. PUR-FORM Joe Purita, MD #AHealthyPointOfViewPodcast #AgeManagement #Wellness #FunctionalMedicine #PurForm #DrJosephPurita #Viral #OOTD #Fashion #HealthTok #HealthTips #HealthyTips #IVDrips #Liquivida #SamTejada #Stemcell #VO2Max #DexaScan #Biohack #biohacker #WINNERGY

10

Function wants to reimagine healthcare. The preventative diagnostics platform closed a Series A investment led by a16z Bio + Health, bringing its total funding to $53M. Co-founded by functional medicine expert Mark Hyman, MD, the company leverages robust lab testing to improve longevity and healthspan. Taking a proactive approach, twice-annual 100-biomarker panels are reviewed by AI and human clinicians to spot and treat disease. Members can also opt for additional tests as needed. Operating in beta since April, Function Health counts 50K paying customers, a 200K person waitlist, and recently partnered with Equinox. Losing faith in traditional healthcare, more people are seeking preventative scans, alternative medicine, and longevity protocols. Democratizing diagnostics, Function wants to prioritize health over healthcare. 

109

15 Comments

🤔 How do (US) hospitals spend money 101? Salaries, Wages, Benefits: 45-55% Professional Services: 12-22% Supplies: 12-18% Depreciation/Amortization: 3-6% Other Expenses: 5-20% 8 key insights: n°1. Hospitals consume 31% of US healthcare spending: Despite being the largest spending category, many hospitals struggle with low operating margins, often below 2%. n°2. Labor costs dominate hospital expenses: Salaries, wages, and benefits account for 45-55% of a hospital’s expenditures, with front-line staff making up 75-82% of the workforce. n°3. Contract labor adds significant costs: Hospitals often resort to staffing agencies due to labor shortages, paying 2-3 times more for contract workers compared to employed staff. n°4. Supplies account for 12-18% of expenses: This includes medical equipment, drugs, and personal protective equipment. n°5. For-profit vs. non-profit hospitals: For-profit hospitals tend to manage costs more efficiently, keeping salaries and expenses lower, but often at the expense of services like Medicaid or charity care. n°6. Economies of scale in larger health systems: Larger systems benefit from negotiating better prices for supplies and services. n°7. Rural hospitals face unique challenges: Limited access to talent and capital means rural hospitals must rely more heavily on expensive outsourced labor and struggle to offer high-margin services. n°8. Staffing shortages remain a key issue: Despite financial recovery post-COVID for many hospitals, staffing shortages continue, driving hospitals to explore different revenue models and operational changes to sustain profitability.​ Great post by the Out-Of-Pocket team Nikhil Krishnan & Ben Chao #healthcare

5

“So... Apple is entering the hearing space!” For the past two weeks, I've been flooded with messages asking how Apple's latest announcement will impact Concha Labs. Another consumer tech giant is stepping into the hearing space, but what does this really mean? With over 1.5 billion people affected by hearing loss globally, this is a massive market. Yet, like mental health, hearing loss is something people don’t talk about much. If you ask anyone who’s tried hearing aids, you’ll likely hear stories of frustration—they’re often disliked because of impersonal sound quality. For me, they were always too loud or too quiet, and I could never find the “right” fit. This isn’t new. Apple, like Bose before them, will likely face similar challenges in replicating the status quo. Despite their audio expertise, Bose entered the hearing aid space but exited due to the same hurdles. Bluetooth earpieces, with their short battery life and social awkwardness, also highlight how hard it is to create a practical, long-term solution. But here’s the good news: more attention on hearing health, thanks to Apple’s announcement and the OTC Hearing Aid Act, is a win for everyone. It’s sparking conversations about hearing loss—something I kept hidden for decades. Concha Labs' hearing aids are nearly invisible, like contact lenses. When I tell people I’m wearing our product, they’re always shocked because they don’t notice them, even with my hair up! (And this goes for the guys who wear them, too!) What’s clear to me is that while awareness is growing, real innovation comes from solving actual user pain points. That’s where Concha Labs comes in: we offer a fully personalized hearing experience, much like how Spotify revolutionized music personalization beyond iTunes. Our solution is designed for real-world usability—comfortable, discreet, personalized, and customizable in multiple sizes and colors. Created by people who were tired of the status quo (like me!), our Concha Sol hearing aids are made for those who want something better. So, if you’re tired of the same old hearing aids, let Concha Labs empower you to hear clearly. We promise, you’ll notice the difference. 😉 Amy www.conchalabs.com #hearing #hearingaids #apple #conchalabs #invisible #otchearingaids #startup

132

6 Comments

Harnessing Proprietary Information for Strategic Healthcare Investments Healthcare investments offer a unique combination of financial returns and the potential for significant social impact. For family offices and discerning investors, navigating this complex landscape requires more than just capital—it demands strategic insights fueled by proprietary information. The Foundation of Strategic Investment: Proprietary Information In the investment world, knowledge is power. This is particularly true in the healthcare sector, where regulatory landscapes, technological advancements, and policy changes can drastically impact the viability and potential of investment opportunities. Access to proprietary information gives investors a critical edge, enabling them to: - Anticipate Market Movements: With insights into healthcare policies and emerging trends, investors can position their portfolios to capitalize on upcoming shifts in the market. - Enhance Due Diligence: Tailored underwriting and due diligence tools grounded in exclusive data can highlight risks and reveal hidden potentials in investment prospects. - Maximize Value Creation: By understanding the intricacies of the US healthcare economy, investors can devise strategies for long-term value creation, rather than short-term gains. Empowering Family Offices Family offices often seek investments that offer both competitive financial returns and the opportunity to create a positive legacy. By refining investment platforms to address the specific needs of these entities, such as instant diversification and upside capture, they can achieve their financial and legacy-driven goals. These platforms can provide: - Market Insights: Curated intelligence that focuses on the most promising healthcare segments. - Educational Resources: In-depth content to deepen the understanding of healthcare technology trends and investment strategies. Building Relationships and Trust Investing is not just about the numbers; it's also about people. To attract and retain high-potential family office prospects, investment platforms must foster empathy and engagement. This involves: - Offering Exclusive Rights: Providing access to follow-on deals and direct investment opportunities with board or advisory roles. - Understanding Emotions: Addressing fears of missing out on prime opportunities due to geographical limitations and dissatisfaction with average investment options. - Creating Community: Facilitating a network of like-minded investors focused on collaborative, high-impact healthcare investments. Harnessing proprietary information is critical for making strategic healthcare investments that offer significant financial returns and contribute to the betterment of society. If you like to learn more about strategic healthcare investments or discuss your specific investment goals and how proprietary information can be leveraged to achieve them? Please feel free to reach out or leave a comment below.

20

1 Comment

Digital health isn't just about apps and wearables. It's about rewiring our neural circuitry for wellbeing. Join me on Charmhealth's podcast as we explore the frontier of brain-based behavior change. #DigitalHealth #NeuroscienceRevolution https://lnkd.in/gTFka44P

4

Anne Wojcicki, CEO of 23andMe, has announced plans to take the genetic testing company private. This strategic move aims to provide more flexibility in navigating regulatory challenges and to accelerate growth opportunities. The decision follows a trend of health tech companies seeking private ownership to focus on long-term objectives. Wojcicki highlighted the importance of this shift to maintain the company's commitment to innovation and customer-centric services. Taking 23andMe private reflects a bold step towards enhancing its position in the rapidly evolving genomics industry. Read more about this exciting development here: https://lnkd.in/gdrC3a64 #genomics #IPO #privatisation #23andMe

13

It was a pleasure to host 5 amazing humans working hard to improve healthcare through investing in innovative startups. In this webinar we discuss 1. Due diligence in healthcare startups 2. What investors look for in founders 3. Opportunities in remote patient monitoring 4. Opportunities in AI scribes 5. Portfolio construction 6. Power law in healthcare investing Thank you to: Allan May Dr. Shaun Kuan Thanasi Tsiodras Regina Prasad, MS Greg Buchert, MD, MPH For taking the time to join me and sharing their wisdom! https://lnkd.in/d5z_XtEM #healthcare #venturecapital #angelinvesting

27

5 Comments

🌟 Exciting News in the Fight Against Homelessness in California! 🌟 🏠 Imagine a world where healthcare extends beyond the hospital walls and directly into the communities that need it most. That's exactly what California is pioneering with its CalAIM initiative! Launched in 2022, CalAIM is transforming how Medi-Cal, California’s Medicaid program, addresses homelessness by integrating healthcare with critical housing support services. 🤯 Did you know? In 2023 alone, over 68,600 Californians benefited from CalAIM’s “housing trio” services, which help individuals secure housing, maintain their living situations, and manage initial move-in costs. But that's not all - the program also offers medically tailored meals, medical respite care, and more, all designed to create a healthier, more stable environment for those in need. 🔄 However, there’s a catch - this groundbreaking program operates under federal waivers that are set to expire at the end of 2026. The future of CalAIM hangs in the balance, depending on the renewal decisions of the federal administration. This uncertainty poses a significant challenge to the continuity of services that many depend on. 🔍 Looking ahead, California advocates are pushing to make these essential services a permanent part of Medi-Cal, aiming to safeguard the future of healthcare and housing integration. This proactive approach illustrates the critical need for sustainable solutions in addressing homelessness. 🏛️ At PHOCIS Capital™, we believe in the power of sustainable development and the role of private money in driving social change. Our commitment to financial empowerment and success ties directly into initiatives like CalAIM, where thoughtful investment can yield transformative societal impacts. 💬 We'd love to hear your thoughts! How do you see the integration of healthcare and housing evolving? What role can private investors play in supporting initiatives like CalAIM? 👍 Like, comment, and share to spread the word about this innovative approach to tackling homelessness! 📢 #RegisterNow to stay updated on how you can contribute through impactful investments with PHOCIS Capital™. #HousingForAll #SustainableDevelopment #PrivateMoney #fixandflip #hardmoney #FinancialEmpowerment #RealEstateHumor 🔗 [Your thoughts and actions can help pave the way for a brighter, healthier future!]

1

I’m worried about the state of venture capital and direct-to-consumer (DTC) healthcare startups. Hims & Hers is the poster child for DTC healthcare at $1.2B proj 2024 revenue and a $3.6B valuation. By most accounts, they have been an outlier success for DTC since bottoming out in May 2022. So why is this bad news for DTC healthcare? Because the market leader (Hims) trades at a 3x forward revenue multiple. And the category leader typically gets a higher valuation multiple than smaller startups. We see this phenomenon in private equity. They “roll up” smaller companies within the same category at a lower multiples just to create one larger platform that trades at higher multiples. Now back to DTC healthcare startups. If Hims commands a 3x revenue multiple, it’s not unrealistic that smaller, unprofitable startups may be valued 1-2x revenue at exit. At 2x revenue, a startup must generate $500M to produce a $1B exit in today’s market (depending on growth and profitability). Series A/B venture capitalists must see a pathway to $1B outcomes. And if the growth-stage investors with billions under management are less interested in DTC healthcare, the future funding rounds necessary for fueling growth are not guaranteed. Juxtapose this against 2017-2022 where DTC could raise Series B-E funding. Let’s take a DTC startup doing $25M after 3-4 years of operations and has already raised a Series A. By most accounts, it would be a phenomenal accomplishment. But today, investors will question the chances of that same company scaling from $25M to $500M revenue in the next 3-4 years with unknown future funding sources from Series B and beyond. You're stuck in VC-funding purgatory. Some of these companies will shut down. Some may sell for 1-3x revenue. And some may try to transition to profitable, cash-flowing businesses. All of which are certainly not the venture-backed goal the founders, investors, and employees often had in mind when first taking capital. I say this all with friends working at or starting DTC healthcare companies, I feel bad for them. I also feel bad for the patients who enjoy those products or services. To caveat (b/c I know people will object), there will be other DTC brands that exit for $1B+ (i.e., Ro). However, they were forged and scaled during a different time period where seemingly endless venture capital was available for DTC healthcare. Now we're in a different time with no end in sight. Thoughts?

149

36 Comments

***From Best Practices to Next Practices*** This article from Jon Warner and Jomo Kenneth Starke discusses the shift from Return on Investment (ROI) to Return on Value (ROV) in healthcare, emphasizing a holistic approach that includes innovation, impact, and investment returns. ​ ROV considers qualitative factors alongside financial gains, guiding organizations to align investments with their missions. ​ It encourages long-term perspectives, justifying patient capital for incremental value creation. ​ Challenges in quantifying non-financial returns are acknowledged, but the benefits of ROV outweigh them. ​ This framework aids in strategic decision-making, resource allocation, and partnership formation to maximize value for individuals and society. ​ #Healthcare #ReturnOnValue #Innovation #PatientOutcomes #Collaboration #nextgen #valueovervolume https://lnkd.in/gihZBhSY

27

8 Comments

AI and Med Tech in Focus   AI System Developed to Identify Pathology in Tissues Engineers at Washington State University have developed an AI tool that uses images of human and animal tissue to detect abnormalities faster and more accurately than people. The AI algorithm was trained using images from past studies that involved kidney, testes, ovarian, prostate, breast and lymph node abnormalities. The new model detected disease in minutes—current processes take humans several hours and require specialized teams to check each other’s work. It was also found to be more accurate, sometimes detecting instances that humans had missed. The engineers designed the system to handle the processing load of the high-resolution gigapixel images by breaking them down into smaller tiles but still retaining the overall context of the tissue sample—akin to the zoom feature on a microscope or phone camera. Aside from getting diagnostic results more accurately and quickly, the new system also shows promise in epigenetics (the study of molecular processes that change gene behavior without changing underlying DNA). Epigenetic researchers can perform analyses and get results that used to take a year or more in just a couple of weeks. VC Investors are always adjusting their "Play Book" with a variety of options for investing. Mikal Ventures is one of those alternatives, offering curated solutions to real world problems. Reach out if you have questions on how we can be of assistance and bookmark https://mikalventures.com/ for additional insights and information.

1

As entrepreneurs in the field of medical communications, our mission is to bridge the gap between groundbreaking science and meaningful healthcare outcomes. Every day, we're challenged to think beyond the ordinary—whether it's finding creative ways to educate healthcare professionals, developing patient-centered campaigns, or integrating the latest digital tools to enhance engagement. Contrary to what some may feel, I find inspiration in how AI enables our roles as humans to evolve—pushing us to focus on creativity, strategy, and deeper connections. …It’s a reminder that our role isn’t just to deliver information—it’s to spark understanding, drive change, and ultimately improve lives. At MedPlan, we're passionate about staying ahead of the curve: 🔍 Exploring new ways to tailor medical education. 💡 Harnessing creativity to connect science with impactful storytelling. 🤝 Building partnerships that advance healthcare goals. Entrepreneurship in this field isn’t without its challenges, but with every challenge comes the opportunity to grow and innovate. Let’s continue to push boundaries, learn from each other, and shape the future of medical communication. A few thought-provoking articles that have captured my attention, highlighting the transformative potential of innovation in community health, administrative efficiency, and the pioneering efforts of forward-thinking companies: How one LA doctor is using AI to help homeless communities get medical care: https://lnkd.in/e4Xv3mVJ What the AI revolution means for your health: https://lnkd.in/e7hsjRhU Zoom to use AI for medical notes during telehealth doctor visits: https://lnkd.in/ey6q5V6c AI and Medical Communications: https://lnkd.in/eUnUKjDe https://lnkd.in/emJsbw83 AI-Driven Behavior Change in Health Care: https: //https://lnkd.in/e6jcHmu8

13